Search - tctmd.com

Displaying 281 - 300 of 651

Sort: Relevancy | Date

Presentation TCT 2019

Case Viewpoint: Treat Both the MR and TR

Presenter: Neil Fam, MD

September 28, 2019

Presentation TCT 2019

Case Viewpoint: Treat the MR Only

Presenter: Magnus Settergren

September 28, 2019

Presentation TCT 2019

Case Presentation: Severe DMR and Severe TR

Presenter: Anita Asgar

September 28, 2019

Presentation TCT 2019

State-of-the-Art Medical Therapy for Treatment of Tricuspid Regurgitation and Its Effect on Prognosis

Presenter: Linda Gillam

September 28, 2019

Presentation TCT 2019

Case Resolution: How We Treated Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Presenter: Howard Herrmann

September 28, 2019

Presentation TCT 2019

Case Viewpoint: Treat the MR; Conservative Management for the AS

Presenter: Brij Maini

September 28, 2019

Presentation TCT 2019

Case Introduction: Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Presenter: Howard Herrmann

September 28, 2019

Presentation TCT 2019

Combined Low-Flow, Low-Gradient Aortic Stenosis and Functional Mitral Regurgitation: A Diagnostic Challenge

Presenter: Rebecca Hahn

September 28, 2019

Presentation TCT 2019

ICE Guidance as the Primary Strategy for LAA Closure: Technique and Data

Presenter: Mohamad Alkhouli

September 27, 2019

Presentation TCT 2019

Utility of CT for Pre-Procedural Planning and Device Selection

Presenter: Michael Rinaldi

September 27, 2019

Presentation TCT 2019

Case-Based Device Selection: Matching the Device With the Anatomy

Presenter: Reda Ibrahim

September 27, 2019

Presentation TCT 2019

Residual Leak and Ischemic Stroke After LAA Closure: Whether to Close and if So, How?

Presenter: George Hanzel

September 27, 2019

Presentation TCT 2019

Optimal Timing for Surveillance Imaging After LAAC

Presenter: Saibal Kar

September 27, 2019

Presentation TCT 2019

Critical Appraisal of Post-LAA Closure Pharmacology and Device-Related Thrombus

Presenter: Kishore Harjai

September 27, 2019

Presentation TCT 2019

Device-Related Thrombus: Mechanisms, Management, and Implications for Device Design

Presenter: Simon Cheung-chi Lam

September 27, 2019

Presentation TCT 2019

Epicardial LAAC to Reduce Atrial Fibrillation: AMAZE Rationale and Status

Presenter: DJ Lakkireddy

September 26, 2019

Presentation TCT 2019

TAVR Followed by LAA Closure: Implications for Bleeding, Stroke, and HALT

Presenter: Fabian Nietlispach

September 26, 2019

Presentation TCT 2019

LAA Closure in Patients With Prior Intracranial Hemorrhage

Presenter: Jens Erik Nielsen-Kudsk

September 26, 2019

Presentation TCT 2019

Clinical Rationale for LAA Closure After AF Ablation

Presenter: DJ Lakkireddy

September 26, 2019

Presentation TCT 2019

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Presenter: Brian Whisenant

September 26, 2019

Advertisement

Case Viewpoint: Treat Both the MR and TR

Case Viewpoint: Treat the MR Only

Case Presentation: Severe DMR and Severe TR

State-of-the-Art Medical Therapy for Treatment of Tricuspid Regurgitation and Its Effect on Prognosis

Case Resolution: How We Treated Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Case Viewpoint: Treat the MR; Conservative Management for the AS

Case Introduction: Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Combined Low-Flow, Low-Gradient Aortic Stenosis and Functional Mitral Regurgitation: A Diagnostic Challenge

ICE Guidance as the Primary Strategy for LAA Closure: Technique and Data

Utility of CT for Pre-Procedural Planning and Device Selection

Case-Based Device Selection: Matching the Device With the Anatomy

Residual Leak and Ischemic Stroke After LAA Closure: Whether to Close and if So, How?

Optimal Timing for Surveillance Imaging After LAAC

Critical Appraisal of Post-LAA Closure Pharmacology and Device-Related Thrombus

Device-Related Thrombus: Mechanisms, Management, and Implications for Device Design

Epicardial LAAC to Reduce Atrial Fibrillation: AMAZE Rationale and Status

TAVR Followed by LAA Closure: Implications for Bleeding, Stroke, and HALT

LAA Closure in Patients With Prior Intracranial Hemorrhage

Clinical Rationale for LAA Closure After AF Ablation

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content